Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2a trial of intra-articular Allocetra for knee osteoarthritis
MOH_2024-01-15_012758Phase 2Completed
- Sponsor
- Enlivex Therapeutics
- Start
- Aug 2023
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Allocetra in knee osteoarthritis (OA) (3 arms), sponsored by Enlivex Therapeutics. Primary endpoint: Not reported. Started Aug 2023; status: completed.
02
Drugs
Allocetra
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on MOH_2024-01-15_012758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2024-01-15_012758.